Results 121 to 130 of about 10,211 (187)

Salivary Metabolomics Discloses Metabolite Signatures of Oral Leukoplakia with and Without Dysplasia. [PDF]

Int J Mol Sci
Ferrari E, Antonelli R, Gallo M, Meleti M, Setti G, Mucci A, Righi V, Gambini A, Magnoni C, Spisni A, Pertinhez TA.   +10 more
europepmc   +1 more source

Next-generation AI framework for comprehensive oral leukoplakia evaluation and management. [PDF]

NPJ Digit Med
Li J, Zhou Y, Zhang M, Adeoye J, Pu JJ, Zhou M, Liu C, Fan L, McGrath C, Zhang D, Zheng L.   +10 more
europepmc   +1 more source

Activated carbon attenuates nicotine and Candida albicans-induced oral leukoplakia via modulation of IL-17R signaling and oxidative stress: an in vivo study. [PDF]

Head Face Med
Arma U, Bakar A, Mailiza F, Orienty FN, Gani BA.   +4 more
europepmc   +1 more source

Predicting Malignant Transformation in Oral Leukoplakia: A Multilayer Perceptron Approach Incorporating Clinicopathological Features and DNA Content. [PDF]

J Oral Pathol Med
Pontes GI, Araújo ALD, Soares AB, Warnakulasuriya S, de Freitas ALS, Stevão CG, Sperandio M, Moraes MC.   +7 more
europepmc   +1 more source

Malignant Transformation of Oral Leukoplakia and Proliferative Verrucous Leukoplakia and Its Biomarker Predictors: A Systematic Umbrella Review. [PDF]

Head Neck
Fatih MT, Mahmood MK, Garib BT, Amin YMM, Talabani RM, Rasheed TA, Kurda HA, Qadir BH, Noori ZF, Abdulghafor MA, Saeed AO, Tassery H, Tardivo D, Lan R.   +13 more
europepmc   +1 more source

Immunohistochemical expression of epithelial mesenchymal transition proteins ZEB1 and E-cadherin in oral leukoplakia and oral squamous cell carcinoma. [PDF]

World J Exp Med
Panchannavar GS, Angadi PV.
europepmc   +1 more source

Comparative evaluation of Plasma and Salivary 8-isoprostane expression in Oral Leukoplakia and Oral Submucous Fibrosis patients. [PDF]

J Oral Maxillofac Pathol
Ramesh P, Warrier SA, Venugopal DC.
europepmc   +1 more source

Evaluating the diagnostic value and prospects of genomic and mutational sequencing in malignant transformation of oral leukoplakia. [PDF]

J Dent Sci
Yuan J, Zhu Y, Wang Z, Lv Z, Liu W.
europepmc   +1 more source

FAP promotes progression of oral leukoplakia via activation of PI3K/AKT pathway by interacting with ITGB1. [PDF]

Transl Oncol
Li R, Liu T, Gu Y, Gao Y, Jiao X, Li Y, Tian S, Cao K.   +7 more
europepmc   +1 more source